~~<i id='E673FAF0D1'><strike id='E673FAF0D1'><tt id='E673FAF0D1'><pre id='E673FAF0D1'></pre></tt></strike></i>~~

Home» leisure time» leisure time

leisure time

author：fashion 2025-09-27 10:53:20 Page View：445

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FTC sues over Novant Health acquisition of two N.C. hospitals
Next article： Hollywood unions extend contract negotiations for actors

explore

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

What American doctors can learn from their Israeli counterparts

IsraelisgatherinTelAvivforthe34thconsecutiveweektoprotestagainstplansbyPrimeMinisterBenjaminNetanyah

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

Snackable artificial intelligence, expert AI, and the pharma industry

AdobeWhileit’swidelyacceptedthatthepharmaindustryisinnovativeinR&D,itisalsotruethatitcanbeslowat